Published in Cancer Weekly, December 5th, 2006
The Board of Directors has formed a committee to immediately initiate a search for his successor. As chief technology officer, Cutrer would, in addition to other responsibilities, continue to play an active leadership role in the company's breast brachytherapy program and to remain a member of the company's Board of Directors.
Gary N. Wilner, MD, chairman of the company's Board of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.